Side Effects and Its Management in Adjuvant Endocrine Therapy for Breast Cancer: A Matter of Communication and Counseling

• Published in: Breast cancer : basic and clinical research 2023-01, Vol.17, p.11782234221145440-11782234221145440
• Main Authors: Johnsson, Aina, Fugl-Meyer, Kerstin, Bordas, Pal, Åhman, Janet, Von Wachenfeldt, Anna
• Format: Article
• Language: English
• Subjects: anti-hormonal side effects; Breast cancer; Endocrine therapy; focus groups; Medicin och hälsovetenskap; Original; professional support; sexuality; Womens health
• ISSN: 1178-2234; 1178-2234
• DOI: 10.1177/11782234221145440

Objective: Women with a newly diagnosed hormone receptor-positive breast cancer are offered adjuvant endocrine therapy (AET). Although the treatment reduces the risk of relapse and death not all women are adherent to it. Many factors, including the therapy’s menopausal side effects, can adversely affect adherence to the treatment. This study explores the extent to which women treated with AET perceived that health care providers addressed their side effects. Methods: Ten focus groups were set up, containing between four to nine women. In total, 58 women participated in the study—45 from the Stockholm metropolitan region and 13 from the scarcely populated Norrbotten region. The interviews were analyzed using qualitative content analysis with an inductive approach. Results: The women were usually satisfied with the care they received from the health care providers. However, their experiences were more complex when it came to their satisfaction with the care in terms of the menopausal side effects of therapy, sexuality in particular. The participants reported that their healthcare providers rarely asked about sex life-related side effects of the treatment. Conclusions: Health care providers need to communicate and consult about issues related to their patients’ sex lives following their breast cancer diagnosis and during their treatment.